1Kreeger K. From bench to bedside. Nature,2003, 424: 1090- 1091.
2Ledford H. Translational research: the full cycle. Nature, 2008, 453:843-845.
3Cesario A, Galetta D, Russo P, et al. The role of the surgeon in translational research. Lancet,2003, 362 : 1082.
4Finkelstein SE, Heimann DM, Klebanoff CA, et al. Bedside to bench and back again: how animal models are guiding the development of new immunotberapies for cancer. J Leukoc Biol, 2004, 76 : 333-337.
5Morrow GR, Bellg AJ. Behavioral science in translational research and cancer control. Cancer, 1994, 74 Suppl:1409-1417.
6Preusser M, Heinzl H, Gelpi E, et al, Histopathologie assessment of hot-spot mierovessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Cancer,2006, 107:162-170.
7Garfield SA, Malozowski S, Chin MH, et al. Considerations for diabetes translational research in real-world settings. Diabetes Care, 2003, 26:2670-2674.
8Cripe TP, Thomson B, Boat TF, et al. Promoting translational research in academic health centers : navigating the " roadmap". Aead Med,2005, 80 : 1012-1018.
9Zerhouni E. Medicine. The NIH Roadmap. Science,2003, 302: 63 -72.
10Fontanarosa PB, DeAngelis CD. Translational medical research. JAMA,2003, 289:2133.
